SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 137 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,089 | -69.4% | 31,826 | -33.7% | 0.00% | – |
| Q2 2023 | $62,373 | -79.4% | 47,979 | -72.1% | 0.00% | – |
| Q1 2023 | $302,935 | -43.1% | 172,122 | +1.5% | 0.00% | -100.0% |
| Q4 2022 | $532,277 | -31.1% | 169,515 | +7.5% | 0.00% | 0.0% |
| Q3 2022 | $773,000 | +19.7% | 157,737 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $646,000 | -28.5% | 156,129 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $903,000 | -28.6% | 155,424 | -7.8% | 0.00% | 0.0% |
| Q4 2021 | $1,264,000 | -14.2% | 168,498 | +3.0% | 0.00% | -50.0% |
| Q3 2021 | $1,473,000 | -24.1% | 163,526 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $1,940,000 | -10.8% | 162,056 | -6.7% | 0.00% | -33.3% |
| Q1 2021 | $2,176,000 | -20.1% | 173,633 | -0.4% | 0.00% | -25.0% |
| Q4 2020 | $2,722,000 | +64.6% | 174,402 | -0.3% | 0.00% | +33.3% |
| Q3 2020 | $1,654,000 | +5.5% | 174,976 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,568,000 | +41.6% | 174,976 | +0.7% | 0.00% | +50.0% |
| Q1 2020 | $1,107,000 | -24.2% | 173,786 | -0.4% | 0.00% | 0.0% |
| Q4 2019 | $1,461,000 | -10.1% | 174,527 | -2.8% | 0.00% | -33.3% |
| Q3 2019 | $1,626,000 | -14.6% | 179,615 | +1.6% | 0.00% | -25.0% |
| Q2 2019 | $1,905,000 | +27.7% | 176,863 | +13.1% | 0.00% | +33.3% |
| Q1 2019 | $1,492,000 | -18.2% | 156,415 | -1.5% | 0.00% | -25.0% |
| Q4 2018 | $1,824,000 | -30.6% | 158,844 | +2.4% | 0.00% | -20.0% |
| Q3 2018 | $2,630,000 | +19.3% | 155,154 | -0.0% | 0.01% | 0.0% |
| Q2 2018 | $2,204,000 | -9.2% | 155,209 | +21.5% | 0.01% | 0.0% |
| Q1 2018 | $2,426,000 | +11.9% | 127,696 | -3.4% | 0.01% | +25.0% |
| Q4 2017 | $2,168,000 | +8.9% | 132,173 | -0.4% | 0.00% | 0.0% |
| Q3 2017 | $1,991,000 | +79.0% | 132,741 | +5.0% | 0.00% | +100.0% |
| Q2 2017 | $1,112,000 | +56.4% | 126,381 | -7.6% | 0.00% | +100.0% |
| Q1 2017 | $711,000 | +63.1% | 136,781 | -4.3% | 0.00% | 0.0% |
| Q4 2016 | $436,000 | -35.8% | 142,881 | -2.5% | 0.00% | 0.0% |
| Q3 2016 | $679,000 | -19.5% | 146,581 | +0.5% | 0.00% | -50.0% |
| Q2 2016 | $844,000 | -5.4% | 145,781 | -1.1% | 0.00% | 0.0% |
| Q1 2016 | $892,000 | -24.2% | 147,381 | +14.3% | 0.00% | -33.3% |
| Q4 2015 | $1,177,000 | +64.8% | 128,941 | +1.8% | 0.00% | +50.0% |
| Q3 2015 | $714,000 | -49.3% | 126,684 | -0.3% | 0.00% | -33.3% |
| Q2 2015 | $1,409,000 | -27.8% | 127,084 | +2.1% | 0.00% | -40.0% |
| Q1 2015 | $1,952,000 | +1.3% | 124,482 | -1.7% | 0.01% | 0.0% |
| Q4 2014 | $1,927,000 | +5.0% | 126,682 | -25.6% | 0.01% | 0.0% |
| Q3 2014 | $1,835,000 | -3.1% | 170,189 | +37.2% | 0.01% | 0.0% |
| Q2 2014 | $1,894,000 | -13.7% | 124,034 | +2.2% | 0.01% | -16.7% |
| Q1 2014 | $2,194,000 | +43.1% | 121,334 | +10.0% | 0.01% | +50.0% |
| Q4 2013 | $1,533,000 | +36.5% | 110,334 | +3.0% | 0.00% | +33.3% |
| Q3 2013 | $1,123,000 | +53.6% | 107,134 | +14.4% | 0.00% | +50.0% |
| Q2 2013 | $731,000 | -16.2% | 93,658 | +2.7% | 0.00% | -33.3% |
| Q1 2013 | $872,000 | – | 91,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |